New tools to connect with independent in-person and telehealth providers specializing in Alzheimer's disease are designed to increase capacity and reduce delays in diagnosis INDIANAPOLIS, March 27, ...
Health system changes that bolster access to disease-modifying treatments for Alzheimer’s disease could reduce the disparities in diagnosis and improve health equity in disease treatment overall, ...
Panelists discuss how health care institutions are leveraging strategic referral networks and telemedicine technologies to bridge geographical barriers, connect rural patients with specialized ...
It can take months or years for doctors to determine whether people with early signs of memory loss have Alzheimer's disease. But experts say a new generation of blood tests may replace the expensive ...
U.S. Senators Catherine Cortez Masto (D-Nev.), Susan Collins (R-Maine), Mark Warner (D-Va.), and Shelley Moore Capito (R-W. Va.) introduced the bipartisan Alzheimer’s Screening and Prevention (ASAP) ...
Alzheimer’s is a progressive, fatal disease that boggled scientists for a century. In the past 30 years, $42 billion has been invested in research and development of drugs that could treat it. More ...
Health Canada has approved Eli Lilly’s donanemab (Kisunla™) for people with mild cognitive impairment or early-stage Alzheimer’s, making it the country’s second disease-modifying treatment. Clinical ...
The NHS will not be rolling out two new drugs that have been hailed as landmark treatments for Alzheimer's disease. Lecanemab and donanemab are the first drugs to slow the progress of the disease but ...
After a lull of nearly 2 decades, the Food and Drug Administration (FDA) has approved some novel drugs for the treatment of Alzheimer’s disease since 2021. Most of these drugs are antibody therapies ...
A study has identified three distinct pathways in how Alzheimer’s develops, offering insight into how Alzheimer’s cognitive ...
COLUMBIA, S.C. (WIS) - A diagnosis of Alzheimer’s isn’t just fatal but can also be incredibly overwhelming to the person diagnosed and their loved ones. Advocates in the fight against this disease say ...
Alzheimer’s is a progressive, fatal disease that boggled scientists for a century. In the past 30 years, $42 billion has been invested in research and development of drugs that could treat it. More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results